{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:01:27Z","timestamp":1780624887899,"version":"3.54.1"},"reference-count":221,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08120-2","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:36:32Z","timestamp":1776868592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tryptophan metabolism in glaucomatous optic neuropathy: from metabolic dysregulation to therapeutic opportunities"],"prefix":"10.1186","volume":"24","author":[{"given":"Ning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7797-8718","authenticated-orcid":false,"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1737-1217","authenticated-orcid":false,"given":"Wenyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"4","key":"8120_CR1","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3390\/nu11040822","volume":"11","author":"R Doherty","year":"2019","unstructured":"Doherty R, Madigan S, Warrington G, Ellis J. Sleep and Nutrition interactions: implications for athletes. Nutrients. 2019;11(4):822. https:\/\/doi.org\/10.3390\/nu11040822.","journal-title":"Nutrients"},{"issue":"4","key":"8120_CR2","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/ijms22041921","volume":"22","author":"R Zulpaite","year":"2021","unstructured":"Zulpaite R, Miknevicius P, Leber B, Strupas K, Stiegler P, Schemmer P. Tryptophan metabolism via kynurenine pathway: role in solid organ transplantation. IJMS. 2021;22(4):1921. https:\/\/doi.org\/10.3390\/ijms22041921.","journal-title":"IJMS"},{"key":"8120_CR3","doi-asserted-by":"publisher","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18(5):p. 379\u2013401. https:\/\/doi.org\/10.1038\/s41573-019-0016-5.","DOI":"10.1038\/s41573-019-0016-5"},{"issue":"19","key":"8120_CR4","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.3390\/nu16193380","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen X, Xu D, Yu J, Song X-J, Li X, Cui Y-L. Tryptophan metabolism disorder-triggered diseases, mechanisms, and therapeutic strategies: a scientometric review. Nutrients. 2024;16(19):3380. https:\/\/doi.org\/10.3390\/nu16193380.","journal-title":"Nutrients"},{"key":"8120_CR5","doi-asserted-by":"publisher","unstructured":"Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: Tryptophan\u2019s metabolites in exercise, inflammation, and mental health. Science. 2017;357(6349). https:\/\/doi.org\/10.1126\/science.aaf9794.","DOI":"10.1126\/science.aaf9794"},{"key":"8120_CR6","doi-asserted-by":"publisher","unstructured":"Modoux M, et al. Tryptophan metabolism as a pharmacological target. Trends Pharmacol Sci. 2021;42(1):p. 60\u201373. https:\/\/doi.org\/10.1016\/j.tips.2020.11.006.","DOI":"10.1016\/j.tips.2020.11.006"},{"key":"8120_CR7","doi-asserted-by":"publisher","unstructured":"Mancino R, Martucci A, Cesareo M, Giannini C, Corasaniti MT, Bagetta G, et al. Glaucoma and Alzheimer disease: one Age-related neurodegenerative disease of the brain. CN. 2018;16(7):p. 971\u2013977. https:\/\/doi.org\/10.2174\/1570159X16666171206144045.","DOI":"10.2174\/1570159X16666171206144045"},{"key":"8120_CR8","doi-asserted-by":"publisher","unstructured":"Poon WW, Blurton-Jones M, Tu CH, Feinberg LM, Chabrier MA, Harris JW, et al. \u03b2-amyloid impairs axonal BDNF retrograde trafficking. Neurobiol Aging. 2011;32(5):p. 821\u2013833. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.05.012.","DOI":"10.1016\/j.neurobiolaging.2009.05.012"},{"key":"8120_CR9","doi-asserted-by":"publisher","unstructured":"Bayer AU, Keller ON, Francis Ferrari AK-PM. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer\u2019s disease and Parkinson\u2019s disease. Am J Ophthalmol. 2002;133 (1):p. 135\u2013137. https:\/\/doi.org\/10.1016\/s0002-9394(01)01196-5.","DOI":"10.1016\/s0002-9394(01)01196-5"},{"issue":"1","key":"8120_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London A, Benhar I, Schwartz M. The retina as a window to the brain\u2014from eye research to CNS disorders. Nat Rev Neurol. 2013;9(1):44\u201353. https:\/\/doi.org\/10.1038\/nrneurol.2012.227.","journal-title":"Nat Rev Neurol"},{"key":"8120_CR11","doi-asserted-by":"publisher","unstructured":"Yu Y, Fedele G, Celardo I, Loh SHY, Martins LM. Parp mutations protect from mitochondrial toxicity in Alzheimer\u2019s disease. Cell Death Dis. 2021;12(7):p. 651. https:\/\/doi.org\/10.1038\/s41419-021-03926-y.","DOI":"10.1038\/s41419-021-03926-y"},{"key":"8120_CR12","doi-asserted-by":"publisher","unstructured":"Hannappel E, Pankow PG, Grassl F, Brand K, GO. Amino acid pattern in human aqueous humor of patients with senile cataract and primary open-angle glaucoma. Ophthalmic Res. 1985;17(6):341\u201343. https:\/\/doi.org\/10.1159\/000265398.","DOI":"10.1159\/000265398"},{"issue":"7","key":"8120_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.visres.2003.11.003","volume":"44","author":"R Rejdak","year":"2004","unstructured":"Rejdak R, Kohler K, Kocki T, Shenk Y, Turski WA, Okuno E, et al. Age-dependent decrease of retinal kynurenate and kynurenine aminotransferases in DBA\/2J mice, a model of ocular hypertension. Vision Res. 2004;44(7):655\u201360. https:\/\/doi.org\/10.1016\/j.visres.2003.11.003.","journal-title":"Vision Res"},{"issue":"5","key":"8120_CR14","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/ijms21051795","volume":"21","author":"RB Nahomi","year":"2020","unstructured":"Nahomi RB, Nam M-H, Rankenberg J, Rakete S, Houck JA, Johnson GC, et al. Kynurenic acid protects against Ischemia\/Reperfusion-induced retinal ganglion Cell death in mice. IJMS. 2020;21(5):1795. https:\/\/doi.org\/10.3390\/ijms21051795.","journal-title":"IJMS"},{"issue":"13","key":"8120_CR15","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1167\/iovs.19-27565","volume":"60","author":"MM Harper","year":"2019","unstructured":"Harper MM, Woll AW, Evans LP, Delcau M, Akurathi A, Hedberg-Buenz A, et al. Blast preconditioning protects retinal ganglion cells and Reveals targets for Prevention of neurodegeneration following Blast-mediated traumatic Brian Injury. Invest. Ophthalmol. Vis. Sci. 2019;60(13):4159\u201327565. https:\/\/doi.org\/10.1167\/iovs.19-27565.","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"8120_CR16","doi-asserted-by":"publisher","unstructured":"Wang N, Sun C, Yang Y, Zhang D, Huang L, Xu C, et al. Gut microbiota-derived indoleacetic acid attenuates neuroinflammation and neurodegeneration in glaucoma through ahr\/rage pathway. J Neuroinflammation. 2025;22(1):p. 179. https:\/\/doi.org\/10.1186\/s12974-025-03505-4.","DOI":"10.1186\/s12974-025-03505-4"},{"key":"8120_CR17","doi-asserted-by":"publisher","unstructured":"Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23(6):p. 716\u2013724. https:\/\/doi.org\/10.1016\/j.chom.2018.05.003.","DOI":"10.1016\/j.chom.2018.05.003"},{"key":"8120_CR18","doi-asserted-by":"publisher","unstructured":"Badawy A-B. Tryptophan metabolism, disposition and utilization in pregnancy. Biosci Rep. 2015;35(5). https:\/\/doi.org\/10.1042\/BSR20150197.","DOI":"10.1042\/BSR20150197"},{"key":"8120_CR19","doi-asserted-by":"publisher","unstructured":"Stone TW, Darlington LG. The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol. 2013;169(6):p. 1211\u20131227. https:\/\/doi.org\/10.1111\/bph.12230.","DOI":"10.1111\/bph.12230"},{"key":"8120_CR20","doi-asserted-by":"publisher","unstructured":"Badawy AA-B. Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int J?Tryptophan?Res. 2017;10:p. 1178646917691938. https:\/\/doi.org\/10.1177\/1178646917691938.","DOI":"10.1177\/1178646917691938"},{"key":"8120_CR21","doi-asserted-by":"publisher","unstructured":"Rejdak R, \u017barnowski ZT, Turski WA, Okuno E, Kocki, Zag\u00f3rski Z, et al. Presence of kynurenic acid and kynurenine aminotransferases in the inner retina. Neuroreport. 2001;12(17):p. 3675\u20133678. https:\/\/doi.org\/10.1097\/00001756-200112040-00014.","DOI":"10.1097\/00001756-200112040-00014"},{"key":"8120_CR22","doi-asserted-by":"publisher","unstructured":"Zarnowski T, Tulidowicz-Bielak M, Zarnowska I, Mitosek-Szewczyk K, Wnorowski A, Jozwiak K, et al. Kynurenic acid and neuroprotective activity of the ketogenic diet in the Eye. CMC. 2017;24(32):p. 3547\u20133558. https:\/\/doi.org\/10.2174\/0929867324666170509120257.","DOI":"10.2174\/0929867324666170509120257"},{"key":"8120_CR23","doi-asserted-by":"publisher","first-page":"p. 13","DOI":"10.3389\/fcimb.2018.00013","volume-title":"Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism","author":"J Gao","year":"2018","unstructured":"Gao J, et al. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Vol. 8. Front Cell Infect Microbiol; 2018. p. p. 13. https:\/\/doi.org\/10.3389\/fcimb.2018.00013."},{"key":"8120_CR24","doi-asserted-by":"publisher","unstructured":"Wirthgen E, Hoeflich A, Rebl A, G\u00fcnther J. Kynurenic acid: the Janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions. Front. Immunol. 2018;8:p. 1957. https:\/\/doi.org\/10.3389\/fimmu.2017.01957.","DOI":"10.3389\/fimmu.2017.01957"},{"key":"8120_CR25","doi-asserted-by":"publisher","unstructured":"Oxenkrug G. Insulin resistance and dysregulation of tryptophan\u2013kynurenine and kynurenine\u2013nicotinamide adenine dinucleotide metabolic pathways. Mol Neurobiol. 2013;48(2):p. 294\u2013301. https:\/\/doi.org\/10.1007\/s12035-013-8497-4.","DOI":"10.1007\/s12035-013-8497-4"},{"key":"8120_CR26","doi-asserted-by":"publisher","unstructured":"Brundin L, Sellgren CM, Lim CK, Grit J, P\u00e5lsson E, Land\u00e9n M, et al. An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation. Transl Psychiatry. 2016;6(8):e865\u2013865. https:\/\/doi.org\/10.1038\/tp.2016.133.","DOI":"10.1038\/tp.2016.133"},{"key":"8120_CR27","doi-asserted-by":"publisher","unstructured":"Hu P, et al. Increased indoleamine 2, 3-dioxygenase and quinolinic acid expression in microglia and muller cells of diabetic human and rodent retina. Invest Ophthalmol Vis Sci. 2017;58(12):p.5043\u20135055. https:\/\/doi.org\/10.1167\/iovs.17-21654.","DOI":"10.1167\/iovs.17-21654"},{"key":"8120_CR28","doi-asserted-by":"publisher","unstructured":"Sultani G, et al. NAD(+): a key metabolic regulator with great therapeutic potential. J Neuroendocrinol. 2017;29 (10). https:\/\/doi.org\/10.1111\/jne.12508.","DOI":"10.1111\/jne.12508"},{"key":"8120_CR29","doi-asserted-by":"publisher","unstructured":"Zhu H, Yang X, Zhao Y. Recent advances in Current uptake situation, metabolic and nutritional characteristics, health, and safety of dietary tryptophan. J. Agric. Food Chem. 2024;72(13):p. 6787\u20136802. https:\/\/doi.org\/10.1021\/acs.jafc.3c06419.","DOI":"10.1021\/acs.jafc.3c06419"},{"key":"8120_CR30","doi-asserted-by":"publisher","unstructured":"Hrovatin K, Kunej T, Dolzan V. Genetic variability of serotonin pathway associated with schizophrenia onset, progression, and treatment. Am J Med Genet Pt B. 2020;183(2):p. 113\u2013127. https:\/\/doi.org\/10.1002\/ajmg.b.32766.","DOI":"10.1002\/ajmg.b.32766"},{"key":"8120_CR31","doi-asserted-by":"publisher","unstructured":"Manzella CR, et al. Serotonin modulates AhR activation by interfering with CYP1A1-mediated clearance of AhR ligands. Cell Physiol Biochem. 2020;54(1):p. 126\u2013141. https:\/\/doi.org\/10.33594\/000000209.","DOI":"10.33594\/000000209"},{"key":"8120_CR32","doi-asserted-by":"publisher","unstructured":"Zhao D, Yu Y, Shen Y, Liu Q, Zhao Z, Sharma R, et al. Melatonin synthesis and function: evolutionary history in animals and plants. Front. Endocrinol. 2019;10:p. 249. https:\/\/doi.org\/10.3389\/fendo.2019.00249.","DOI":"10.3389\/fendo.2019.00249"},{"key":"8120_CR33","doi-asserted-by":"publisher","unstructured":"Masson J. Serotonin in retina. Biochimie. 2019;161:p. 51\u201355. https:\/\/doi.org\/10.1016\/j.biochi.2018.11.006.","DOI":"10.1016\/j.biochi.2018.11.006"},{"key":"8120_CR34","doi-asserted-by":"publisher","unstructured":"Tosini G, Baba K, Hwang CK, Iuvone PM. Melatonin: an underappreciated player in retinal physiology and pathophysiology. Exp Eye Res. 2012;103:p. 82\u201389. https:\/\/doi.org\/10.1016\/j.exer.2012.08.009.","DOI":"10.1016\/j.exer.2012.08.009"},{"key":"8120_CR35","doi-asserted-by":"publisher","first-page":"p. 15","DOI":"10.1186\/1744-9081-2-15","volume-title":"Melatonin in Alzheimer\u2019s disease and other neurodegenerative disorders","author":"V Srinivasan","year":"2006","unstructured":"Srinivasan V, et al. Melatonin in Alzheimer\u2019s disease and other neurodegenerative disorders. Vol. 2. Behav Brain Funct; 2006. p. p. 15. https:\/\/doi.org\/10.1186\/1744-9081-2-15."},{"key":"8120_CR36","doi-asserted-by":"publisher","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9(1). https:\/\/doi.org\/10.1038\/s41467-018-05470-4.","DOI":"10.1038\/s41467-018-05470-4"},{"key":"8120_CR37","doi-asserted-by":"publisher","unstructured":"Lamas B, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med. 2016;22(6):p. 598\u2013605. https:\/\/doi.org\/10.1038\/nm.4102.","DOI":"10.1038\/nm.4102"},{"key":"8120_CR38","doi-asserted-by":"publisher","unstructured":"Chimerel C, Emery E, Summers D, Keyser U, Gribble F, Reimann F. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. 2014;9(4):p. 1202\u20131208. https:\/\/doi.org\/10.1016\/j.celrep.2014.10.032.","DOI":"10.1016\/j.celrep.2014.10.032"},{"key":"8120_CR39","doi-asserted-by":"publisher","unstructured":"Fiore A, Murray PJ. Tryptophan and indole metabolism in immune regulation. Curr Opin Immunol. 2021;70:p. 7\u201314. https:\/\/doi.org\/10.1016\/j.coi.2020.12.001","DOI":"10.1016\/j.coi.2020.12.001"},{"key":"8120_CR40","doi-asserted-by":"publisher","unstructured":"Gao K, Mu C-L, Farzi A, Zhu W-Y. Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr. 2020;11(3):p. 709\u2013723. https:\/\/doi.org\/10.1093\/advances\/nmz127.","DOI":"10.1093\/advances\/nmz127"},{"key":"8120_CR41","doi-asserted-by":"publisher","unstructured":"Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L. Mitochondrial control of inflammation. Nat Rev Immunol. 2023;23(3):p. 159\u2013173. https:\/\/doi.org\/10.1038\/s41577-022-00760-x.","DOI":"10.1038\/s41577-022-00760-x"},{"key":"8120_CR42","doi-asserted-by":"publisher","unstructured":"Zemitis A, Caikovska L, Vanags J, Fan J, Klavins K, Laganovska G. Altered biopterin-related cofactor metabolism in the aqueous humor of glaucoma patients. Exp Eye Res. 2026;263:p. 110778. https:\/\/doi.org\/10.1016\/j.exer.2025.110778.","DOI":"10.1016\/j.exer.2025.110778"},{"key":"8120_CR43","doi-asserted-by":"publisher","unstructured":"Pulukool SK, Bhagavatham SKS, Kannan V, Sukumar P, Dandamudi RB, Ghaisas S, et al. Elevated dimethylarginine, ATP, cytokines, metabolic remodeling involving tryptophan metabolism and potential microglial inflammation characterize primary open angle glaucoma. Sci Rep. 2021;11(1):p.9766. https:\/\/doi.org\/10.1038\/s41598-021-89137-z.","DOI":"10.1038\/s41598-021-89137-z"},{"key":"8120_CR44","doi-asserted-by":"publisher","first-page":"465939","DOI":"10.1016\/j.chroma.2025.465939","volume":"1750","author":"X Fu","year":"2025","unstructured":"Fu X, Guo W, Cheng Y, Li L. An ultra-high-performance tandem mass spectrometry method to quantify tryptophan metabolites in aqueous humor of primary angle-closure glaucoma patients. J Chromatogr A. 2025;1750:465939. https:\/\/doi.org\/10.1016\/j.chroma.2025.465939.","journal-title":"J Chromatogr A"},{"key":"8120_CR45","doi-asserted-by":"publisher","unstructured":"Yang Y, Wang N, Xu L, Liu Y, Huang L, Gu M, et al. Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia\/reperfusion injury. Cell Death Dis. 2023;14(2):p.92. https:\/\/doi.org\/10.1038\/s41419-023-05616-3.","DOI":"10.1038\/s41419-023-05616-3"},{"key":"8120_CR46","doi-asserted-by":"publisher","unstructured":"Lillo A, Marin S, Serrano-Mar\u00edn J, Binetti N, Navarro G, Cascante M, et al. Targeted metabolomics shows that the level of glutamine, kynurenine, acyl-carnitines and lysophosphatidylcholines is significantly increased in the aqueous humor of glaucoma patients. Front. Med. 2022;9. https:\/\/doi.org\/10.3389\/fmed.2022.935084.","DOI":"10.3389\/fmed.2022.935084"},{"key":"8120_CR47","first-page":"2143","volume-title":"Serotonin levels in aqueous humor of patients with primary open-angle glaucoma","author":"V Zanon-Moreno","year":"2008","unstructured":"Zanon-Moreno V, Mendes-Pinto MP, Alves MM, Garcia-Medina CJ, Vinuesa-Silva JJ, Moreno-Nadal I, et al. Serotonin levels in aqueous humor of patients with primary open-angle glaucoma. Vol. 14. Mol Vis; 2008. p. 2143\u201347."},{"key":"8120_CR48","doi-asserted-by":"publisher","unstructured":"Yoshikawa T, Obayashi K, Miyata K, Saeki K, Ogata N. Decreased melatonin secretion in patients with glaucoma: quantitative association with glaucoma severity in the LIGHT study. J Pineal Res. 2020;69(2). https:\/\/doi.org\/10.1111\/jpi.12662.","DOI":"10.1111\/jpi.12662"},{"key":"8120_CR49","doi-asserted-by":"publisher","unstructured":"Kim JY, Jeong AR, Chin HS, Kim NR. Melatonin levels in patients with primary open-angle glaucoma with high or low intraocular pressure. J Glaucoma. 2019;28(2):p. 154\u2013160. https:\/\/doi.org\/10.1097\/IJG.0000000000001130.","DOI":"10.1097\/IJG.0000000000001130"},{"issue":"2","key":"8120_CR50","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ajo.2006.03.040","volume":"142","author":"C Chiquet","year":"2006","unstructured":"Chiquet C, Claustrat B, Thuret G, Brun J, Cooper HM, Denis P. Melatonin concentrations in aqueous humor of glaucoma patients. Am J Ophthalmol. 2006;142(2):325\u20137.e1. https:\/\/doi.org\/10.1016\/j.ajo.2006.03.040.","journal-title":"Am J Ophthalmol"},{"key":"8120_CR51","doi-asserted-by":"publisher","unstructured":"Ma XP, et al. Melatonin concentrations in serum of primary glaucoma patients. Int J Ophthalmol. 2018;11(8):p. 1337\u20131341. https:\/\/doi.org\/10.18240\/ijo.2018.08.14.","DOI":"10.18240\/ijo.2018.08.14"},{"key":"8120_CR52","doi-asserted-by":"publisher","unstructured":"Gubin D, et al. Melatonin mitigates disrupted circadian rhythms, lowers intraocular pressure, and improves retinal ganglion cells function in glaucoma. J Pineal Res. 2021;70(4):p. e12730. https:\/\/doi.org\/10.1111\/jpi.12730.","DOI":"10.1111\/jpi.12730"},{"issue":"3","key":"8120_CR53","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/ijms22031039","volume":"22","author":"M Fiedorowicz","year":"2021","unstructured":"Fiedorowicz M, Choragiewicz T, Turski WA, Kocki T, Nowakowska D, Wertejuk K, et al. Tryptophan pathway abnormalities in a Murine model of hereditary glaucoma. IJMS. 2021;22(3):1039. https:\/\/doi.org\/10.3390\/ijms22031039.","journal-title":"IJMS"},{"issue":"12","key":"8120_CR54","first-page":"2382","volume":"37","author":"CK Vorwerk","year":"1996","unstructured":"Vorwerk CK, Kreutz MR, Dreyer EB, Sabel BA. Systemic L-kynurenine administration partially protects against NMDA, but not kainate-induced degeneration of retinal ganglion cells, and reduces visual discrimination deficits in adults rats. Invest Ophthalmol Vis Sci. 1996;37(12):2382\u201392.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8120_CR55","doi-asserted-by":"publisher","unstructured":"Fiedorowicz M, Choragiewicz T, Thaler S, Schuettauf F, Nowakowska D, Wojtunik K, et al. Tryptophan and kynurenine pathway metabolites in animal models of retinal and optic nerve damage: different dynamics of changes. Front. Physiol. 2019;10:p. 1254. https:\/\/doi.org\/10.3389\/fphys.2019.01254.","DOI":"10.3389\/fphys.2019.01254"},{"key":"8120_CR56","doi-asserted-by":"publisher","unstructured":"Moreno MC, Campanelli J, Sande P, S\u00e1enz DA, Keller Sarmiento MI, Rosenstein RE. Retinal oxidative stress induced by high intraocular pressure. Free Radical Biol Med. 2004;37(6):p. 803\u2013812. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.06.001.","DOI":"10.1016\/j.freeradbiomed.2004.06.001"},{"key":"8120_CR57","doi-asserted-by":"publisher","unstructured":"Bringer MA, Gabrielle P-H, Bron AM, Creuzot-Garcher C, Acar N. The gut microbiota in retinal diseases. Exp Eye Res. Exp Eye Res. 2022;214:p. 108867. https:\/\/doi.org\/10.1016\/j.exer.2021.108867.","DOI":"10.1016\/j.exer.2021.108867"},{"key":"8120_CR58","doi-asserted-by":"publisher","unstructured":"Xue W, Li JJ, Zou Y, Zou B, Wei L. Microbiota and ocular diseases. Front Cell Infect Microbiol. 2021;11:p. 759333. https:\/\/doi.org\/10.3389\/fcimb.2021.759333.","DOI":"10.3389\/fcimb.2021.759333"},{"key":"8120_CR59","doi-asserted-by":"publisher","unstructured":"Napolitano P, Filippelli M, Davinelli S, Bartollino S, Dell\u2019omo R, Costagliola C. Influence of gut microbiota on eye diseases: an overview. Ann Med. 2021;53(1):p. 750\u2013761. https:\/\/doi.org\/10.1080\/07853890.2021.1925150.","DOI":"10.1080\/07853890.2021.1925150"},{"key":"8120_CR60","doi-asserted-by":"publisher","unstructured":"Guo X, Li C, Zhang J, Sun M, Xu J, Xu C, et al. Chiral nanoparticle-remodeled gut microbiota alleviates neurodegeneration via the gut\u2013brain axis. Nat Aging. 2023;3(11):p. 1415\u20131429. https:\/\/doi.org\/10.1038\/s43587-023-00516-9.","DOI":"10.1038\/s43587-023-00516-9"},{"issue":"6","key":"8120_CR61","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3390\/microorganisms8060894","volume":"8","author":"M Doulberis","year":"2020","unstructured":"Doulberis M, Papaefthymiou A, Polyzos SA, Bargiotas P, Liatsos C, Srivastava DS, et al. Association between active Helicobacter pylori infection and glaucoma: a systematic review and meta-analysis. Microorganisms, Microorganisms. 2020;8(6):894. https:\/\/doi.org\/10.3390\/microorganisms8060894.","journal-title":"Microorganisms"},{"key":"8120_CR62","doi-asserted-by":"publisher","unstructured":"Yang X, et al. Metabolic dysregulation in glaucoma. Clin Exp Optom. 2025;108(7):p. 771\u2013777. https:\/\/doi.org\/10.1080\/08164622.2025.2463502.","DOI":"10.1080\/08164622.2025.2463502"},{"key":"8120_CR63","doi-asserted-by":"publisher","unstructured":"Zarnowska I, Wr\u00f3bel-Dudzi\u0144ska D, Tulidowicz-Bielak M, Kocki T, Mitosek-Szewczyk K, Gasior M, et al. Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy. Seizure. 2019;69:p. 265\u2013272. https:\/\/doi.org\/10.1016\/j.seizure.2019.05.006.","DOI":"10.1016\/j.seizure.2019.05.006"},{"key":"8120_CR64","doi-asserted-by":"publisher","unstructured":"May JA, McLaughlin MA, Sharif NA, Hellberg MR, TR. Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. J Pharmacol Exp Ther. 2003;306(1):p. 301\u2013309. https:\/\/doi.org\/10.1124\/jpet.103.049528.","DOI":"10.1124\/jpet.103.049528"},{"key":"8120_CR65","doi-asserted-by":"publisher","unstructured":"Osborne NN, Wood JPM, Melena J, Chao HM, Nash MS, Bron AJ, et al. 5-Hydroxytryptamine1A agonists: potential use in glaucoma. Evidence from animal studies. Evidence Anim Stud. Eye. 2000;14(3):p. 454\u2013463. https:\/\/doi.org\/10.1038\/eye.2000.131.","DOI":"10.1038\/eye.2000.131"},{"key":"8120_CR66","doi-asserted-by":"publisher","unstructured":"Collier RJ, Patel Y, Martin EA, Dembinska O, Hellberg M, Krueger DS, et al. Agonists at the serotonin receptor (5-HT(1A)) protect the retina from severe photo-oxidative stress. Invest Ophthalmol Vis Sci 2011;52(5):p. 2118\u201326. https:\/\/doi.org\/10.1167\/iovs.10-6304.","DOI":"10.1167\/iovs.10-6304"},{"key":"8120_CR67","doi-asserted-by":"publisher","unstructured":"Tullis BE, Ryals RC, Coyner AS, Gale MJ, Nicholson A, Ku C, et al. Sarpogrelate, a 5-HT2A receptor antagonist, protects the retina from light-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 2015;56(8):p. 4560\u20139. https:\/\/doi.org\/10.1167\/iovs.15-16378.","DOI":"10.1167\/iovs.15-16378"},{"key":"8120_CR68","doi-asserted-by":"publisher","unstructured":"Biswal MR, Ahmed CM, Ildefonso CJ, Han P, Li H, Jivanji H, et al. Systemic treatment with a 5HT1a agonist induces anti-oxidant protection and preserves the retina from mitochondrial oxidative stress. Exp Eye Res. 2015;140:p. 94\u2013105. https:\/\/doi.org\/10.1016\/j.exer.2015.07.022.","DOI":"10.1016\/j.exer.2015.07.022"},{"key":"8120_CR69","doi-asserted-by":"publisher","unstructured":"Collier RJ, Wang Y, Smith SS, Martin E, Ornberg R, Rhoades K, et al. Complement deposition and microglial activation in the outer retina in light-induced retinopathy: inhibition by a 5-HT1A agonist. Invest. Ophthalmol. Vis. Sci. 2011;52(11):p. 8108\u201316. https:\/\/doi.org\/10.1167\/iovs.10-6418.","DOI":"10.1167\/iovs.10-6418"},{"key":"8120_CR70","doi-asserted-by":"publisher","unstructured":"Zheng W, Dryja TP, Wei Z, Song D, Tian H, Kahler KH, et al. Systemic medication associations with presumed advanced or uncontrolled primary open-angle glaucoma. Ophthalmology. 2018;125(7):p. 984\u2013993. https:\/\/doi.org\/10.1016\/j.ophtha.2018.01.007.","DOI":"10.1016\/j.ophtha.2018.01.007"},{"key":"8120_CR71","doi-asserted-by":"publisher","unstructured":"Feng R, et al. Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer\u2019s disease (Review). Mol Med Rep. 2016;13(4):p. 3397\u2013400. https:\/\/doi.org\/10.3892\/mmr.2016.4966.","DOI":"10.3892\/mmr.2016.4966"},{"key":"8120_CR72","doi-asserted-by":"publisher","unstructured":"Ciulla L, Moorthy M, Mathew S, Siesky B, Verticchio Vercellin AC, Price D, et al. Circadian rhythm and Glaucoma: what do we know? J Glaucoma. 2020;29(2):p. 127\u2013132. https:\/\/doi.org\/10.1097\/IJG.0000000000001402.","DOI":"10.1097\/IJG.0000000000001402"},{"key":"8120_CR73","doi-asserted-by":"publisher","unstructured":"Flynn-Evans EE, Tabandeh H, Skene DJ, Lockley SW. Circadian rhythm disorders and Melatonin production in 127 blind women with and without light perception. J Biol Rhythms. 2014;29(3):p. 215\u2013224. https:\/\/doi.org\/10.1177\/0748730414536852.","DOI":"10.1177\/0748730414536852"},{"key":"8120_CR74","doi-asserted-by":"publisher","first-page":"p. 109976","DOI":"10.1016\/j.intimp.2023.109976","volume-title":"Melatonin protects against NMDA-induced retinal ganglion cell injury by regulating the microglia-TNFalpha-RGC p38 MAPK pathway","author":"J Zou","year":"2023","unstructured":"Zou J, et al. Melatonin protects against NMDA-induced retinal ganglion cell injury by regulating the microglia-TNFalpha-RGC p38 MAPK pathway. Vol. 118. Int Immunopharmacol; 2023. p. p. 109976. https:\/\/doi.org\/10.1016\/j.intimp.2023.109976."},{"key":"8120_CR75","doi-asserted-by":"publisher","unstructured":"Alkozi HA, Navarro G, Franco R, Pintor J. Melatonin and the control of intraocular pressure. Prog Retin Eye Res. Prog Retin Eye Res. 2020;75:p. 100798. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.100798.","DOI":"10.1016\/j.preteyeres.2019.100798"},{"key":"8120_CR76","doi-asserted-by":"publisher","unstructured":"Li S, et al. Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3\/IKK\/NF-kappaB signaling via gut microbial tryptophan metabolites. Gut Microbes. 2024;16(1):p. 2374608. https:\/\/doi.org\/10.1080\/19490976.2024.2374608.","DOI":"10.1080\/19490976.2024.2374608"},{"key":"8120_CR77","doi-asserted-by":"publisher","unstructured":"Hwang IK, Yoo K-Y, Li H, Park OK, Lee CH, Choi JH, et al. Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus. J Neurosci Res. 2009;87(9):p. 2126\u20132137. https:\/\/doi.org\/10.1002\/jnr.22030.","DOI":"10.1002\/jnr.22030"},{"issue":"13","key":"8120_CR78","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.3390\/jcm14134529","volume":"14","author":"A Zemitis","year":"2025","unstructured":"Zemitis A, Vanags J, Klavins K, Laganovska G. Assessment of kynurenine pathway enzyme activity in ocular diseases: associations with cataract, diabetes, glaucoma, and pseudoexfoliation syndrome. JCM. 2025;14(13):4529. https:\/\/doi.org\/10.3390\/jcm14134529.","journal-title":"JCM"},{"key":"8120_CR79","doi-asserted-by":"publisher","unstructured":"Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016;22(6):p. 586\u2013597. https:\/\/doi.org\/10.1038\/nm.4106.","DOI":"10.1038\/nm.4106"},{"key":"8120_CR80","doi-asserted-by":"publisher","unstructured":"Wei GZ, et al. Tryptophan-metabolizing gut microbes regulate adult neurogenesis via the aryl hydrocarbon receptor. Proceedings of the National Academy of Sciences. 2021. 118 (27).https:\/\/doi.org\/10.1073\/pnas.2021091118.","DOI":"10.1073\/pnas.2021091118"},{"key":"8120_CR81","doi-asserted-by":"publisher","unstructured":"Serger E, Luengo-Gutierrez L, Chadwick JS, Kong G, Zhou L, Crawford G, et al. The gut metabolite indole-3 propionate promotes nerve regeneration and repair. Nature. 2022;607(7919):p. 585\u2013592. https:\/\/doi.org\/10.1038\/s41586-022-04884-x.","DOI":"10.1038\/s41586-022-04884-x"},{"key":"8120_CR82","doi-asserted-by":"publisher","unstructured":"Cheng L, Wu H, Cai X, Zhang Y, Yu S, Hou Y, et al. A Gpr35-tuned gut microbe-brain metabolic axis regulates depressive-like behavior. Cell Host Microbe. 2024;32(2):p. 227\u2013243.e6. https:\/\/doi.org\/10.1016\/j.chom.2023.12.009.","DOI":"10.1016\/j.chom.2023.12.009"},{"key":"8120_CR83","doi-asserted-by":"publisher","unstructured":"Klaassen I, Noorden CJF, Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res. 2013;34:p. 19\u201348. https:\/\/doi.org\/10.1016\/j.preteyeres.2013.02.001.","DOI":"10.1016\/j.preteyeres.2013.02.001"},{"key":"8120_CR84","doi-asserted-by":"publisher","unstructured":"Lee WJ, et al. Aryl hydrocarbon receptor deficiency augments dysregulated microangiogenesis and diabetic retinopathy. Biomed Pharmacother. 2022;155:p. 113725. https:\/\/doi.org\/10.1016\/j.biopha.2022.113725.","DOI":"10.1016\/j.biopha.2022.113725"},{"key":"8120_CR85","doi-asserted-by":"publisher","unstructured":"Yang TM, Fang T-C, Lee YC, Lee CC, Chan YJ, Fitriana I, et al. Aryl hydrocarbon receptor deficiency Upregulates intercellular adhesion molecule 1 in retinal pigment epithelial cells and contributes to retinal inflammation. Lab Investigation. 2025;105(9):p. 104197. https:\/\/doi.org\/10.1016\/j.labinv.2025.104197.","DOI":"10.1016\/j.labinv.2025.104197"},{"key":"8120_CR86","doi-asserted-by":"publisher","unstructured":"Huang Y, He J, Liang H, Hu K, Jiang S, Yang L, et al. Aryl hydrocarbon receptor regulates Apoptosis and inflammation in a Murine model of experimental autoimmune uveitis. Front. Immunol. 2018;9:p.1713. https:\/\/doi.org\/10.3389\/fimmu.2018.01713.","DOI":"10.3389\/fimmu.2018.01713"},{"key":"8120_CR87","doi-asserted-by":"publisher","unstructured":"Zhang J, et al. Melatonin: unveiling the functions and implications in ocular health. Pharmacological Res. 2024;205. https:\/\/doi.org\/10.1016\/j.phrs.2024.107253.","DOI":"10.1016\/j.phrs.2024.107253"},{"key":"8120_CR88","doi-asserted-by":"publisher","unstructured":"Vandeputte C, Giummelly GP, Atkinson J, Delagrange P, Scalbert E, C. Melatonin potentiates NE-induced vasoconstriction without augmenting cytosolic calcium concentration. Am J Physiol-Heart Circulatory Physiol. 2001;280(1):p. H420\u2013H425. https:\/\/doi.org\/10.1152\/ajpheart.2001.280.1.H420.","DOI":"10.1152\/ajpheart.2001.280.1.H420"},{"key":"8120_CR89","doi-asserted-by":"publisher","unstructured":"Meyer P. Melatonin MT-1-receptor immunoreactivity in the human eye. Br J Ophthalmol. 2002;86(9):p.1053\u20131057. https:\/\/doi.org\/10.1136\/bjo.86.9.1053.","DOI":"10.1136\/bjo.86.9.1053"},{"key":"8120_CR90","doi-asserted-by":"publisher","unstructured":"Savaskan E, Olivieri OG, Brydon L, Jockers, Kr\u00e4uchi K, Wirz-Justice, et al. Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer\u2019s disease. Neurosci Lett. 2001;308(1):p. 9\u201312. https:\/\/doi.org\/10.1016\/s0304-3940(01)01967-x.","DOI":"10.1016\/s0304-3940(01)01967-x"},{"key":"8120_CR91","doi-asserted-by":"publisher","unstructured":"Jeon SJ, Huh J, Jeong E, Park CK, Park HYL. Angiotensin II related glial cell activation and necroptosis of retinal ganglion cells after systemic hypotension in glaucoma. Cell Death Dis. 2022;13(4):p. 323. https:\/\/doi.org\/10.1038\/s41419-022-04762-4.","DOI":"10.1038\/s41419-022-04762-4"},{"key":"8120_CR92","doi-asserted-by":"publisher","unstructured":"Tang L, Zhang C, Yang Q, Xie H, Liu D, Tian H, et al. Melatonin maintains inner blood-retinal barrier via inhibition of p38\/TXNIP\/NF-\u03baB pathway in diabetic retinopathy. J Cellular Physiol. 2021;236(8):p. 5848\u20135864. https:\/\/doi.org\/10.1002\/jcp.30269.","DOI":"10.1002\/jcp.30269"},{"key":"8120_CR93","doi-asserted-by":"publisher","unstructured":"Tang L, et al. Melatonin maintains inner blood-retinal barrier by regulating microglia via inhibition of PI3K\/Akt\/Stat3\/NF-\u03baB signaling pathways in experimental diabetic retinopathy. Frontiers in Immunology. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.831660.","DOI":"10.3389\/fimmu.2022.831660"},{"key":"8120_CR94","doi-asserted-by":"publisher","unstructured":"Yu S, Cui K, Wu P, Wu B, Lu X, Huang R, et al. Melatonin prevents experimental central serous chorioretinopathy in rats. J Pineal Res. 2022;73(1). https:\/\/doi.org\/10.1111\/jpi.12802.","DOI":"10.1111\/jpi.12802"},{"key":"8120_CR95","doi-asserted-by":"publisher","unstructured":"Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res. Prog Retin Eye Res. 2012;31(2):p. 152\u2013181. https:\/\/doi.org\/10.1016\/j.preteyeres.2011.11.002.","DOI":"10.1016\/j.preteyeres.2011.11.002"},{"key":"8120_CR96","doi-asserted-by":"publisher","unstructured":"Wu HQ, Lee S-C, Schwarcz R. Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus. Eur J Pharmacol. 2000;390(3):p. 267\u2013274. https:\/\/doi.org\/10.1016\/s0014-2999(00)00024-8.","DOI":"10.1016\/s0014-2999(00)00024-8"},{"key":"8120_CR97","doi-asserted-by":"publisher","unstructured":"Deora GS, Kantham S, Chan S, Dighe SN, Veliyath SK, McColl G, et al. Multifunctional analogs of Kynurenic acid for the treatment of Alzheimer\u2019s disease: synthesis, Pharmacology, and Molecular modeling studies. ACS Chem. Neurosci. 2017;8(12):p. 2667\u20132675. https:\/\/doi.org\/10.1021\/acschemneuro.7b00229.","DOI":"10.1021\/acschemneuro.7b00229"},{"key":"8120_CR98","doi-asserted-by":"publisher","unstructured":"Zinger A, Barcia C, Herrero MT, Guillemin GJ. The involvement of neuroinflammation and kynurenine pathway in Parkinson\u2019s disease. Parkinsons Dis. 2011;2011:p. 1\u201311. https:\/\/doi.org\/10.4061\/2011\/716859.","DOI":"10.4061\/2011\/716859"},{"key":"8120_CR99","doi-asserted-by":"publisher","unstructured":"Z\u00e1dori D, Nyiri G, Sz\u0151nyi A, Szatm\u00e1ri I, F\u00fcl\u00f6p F, Toldi J, et al. Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington\u2019s disease. J Neural Transm. 2011;118(6):p. 865\u2013875. https:\/\/doi.org\/10.1007\/s00702-010-0573-6.","DOI":"10.1007\/s00702-010-0573-6"},{"key":"8120_CR100","doi-asserted-by":"publisher","unstructured":"Ferreira FS, Schmitz F, Marques EP, Siebert C, Wyse ATS. Intrastriatal quinolinic acid administration impairs redox homeostasis and induces inflammatory changes: prevention by Kynurenic acid. Neurotox Res. 2020;38(1):p. 50\u201358. https:\/\/doi.org\/10.1007\/s12640-020-00192-2.","DOI":"10.1007\/s12640-020-00192-2"},{"key":"8120_CR101","doi-asserted-by":"publisher","unstructured":"Zhou X, Zhang R, Zhang S, Wu J, Sun X. Activation of 5-HT1A receptors promotes retinal ganglion Cell function by inhibiting the cAMP-PKA pathway to modulate presynaptic GABA release in chronic glaucoma. J Neurosci. 2019;39(8):p. 1484\u20131504. https:\/\/doi.org\/10.1523\/JNEUROSCI.1685-18.2018.","DOI":"10.1523\/JNEUROSCI.1685-18.2018"},{"key":"8120_CR102","doi-asserted-by":"publisher","unstructured":"Ye D, Shi XY, Fan Y, Lu M, Bai P, Feng X, et al. Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model. J Pineal Res. 2022;73(4):p. e12828. https:\/\/doi.org\/10.1111\/jpi.12828.","DOI":"10.1111\/jpi.12828"},{"issue":"1","key":"8120_CR103","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/pharmaceutics17010085","volume":"17","author":"SM Martinez","year":"2025","unstructured":"Martinez SM, Inda A, R\u00edos MN, Bessone CDV, Bruera Bossio A, Guido ME, et al. Neuroprotective effect of Melatonin loaded in human serum albumin nanoparticles Applied subconjunctivally in a retinal degeneration animal model. Pharmaceutics. 2025;17(1):85. https:\/\/doi.org\/10.3390\/pharmaceutics17010085.","journal-title":"Pharmaceutics"},{"key":"8120_CR104","doi-asserted-by":"publisher","unstructured":"Alcantara-Contreras S, Baba K, Tosini G. Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse. Neurosci Lett. 2011;494(1):p. 61\u201364. https:\/\/doi.org\/10.1016\/j.neulet.2011.02.056.","DOI":"10.1016\/j.neulet.2011.02.056"},{"key":"8120_CR105","doi-asserted-by":"publisher","unstructured":"Samples JR, K.G. L, AJ. Effect of melatonin on intraocular pressure. Curr Eye Res. 1988;7(7):p. 649\u201353. https:\/\/doi.org\/10.3109\/02713688809033192.","DOI":"10.3109\/02713688809033192"},{"key":"8120_CR106","doi-asserted-by":"publisher","unstructured":"Pescosolido N, Gatto GV, Stefanucci A, D. Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients. Ophthalmic Physiologic Optic. 2015, Mar;35(2):p.201\u2013205. https:\/\/doi.org\/10.1111\/opo.12189.","DOI":"10.1111\/opo.12189"},{"key":"8120_CR107","doi-asserted-by":"publisher","unstructured":"Ismail SA, Mowafi HA. Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia. Anesth Analg. 2009;108(4):p. 1146\u20131151. https:\/\/doi.org\/10.1213\/ane.0b013e3181907ebe.","DOI":"10.1213\/ane.0b013e3181907ebe"},{"key":"8120_CR108","doi-asserted-by":"publisher","unstructured":"Martinez-Aguila A, Fonseca B, Bergua A, Pintor J. Melatonin analogue agomelatine reduces rabbit\u2019s intraocular pressure in normotensive and hypertensive conditions. Eur J Pharmacol. 2013;701(1\u20133):p. 213\u2013217. https:\/\/doi.org\/10.1016\/j.ejphar.2012.12.009.","DOI":"10.1016\/j.ejphar.2012.12.009"},{"key":"8120_CR109","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-\u00c1guila A, Fonseca, P\u00e9rez de Lara MJ, J, Fonseca B. Effect of Melatonin and 5-methoxycarbonylamino-N-Acetyltryptamine on the intraocular pressure of normal and glaucomatous mice. J Pharmacol Exp Ther. 2016;357(2):p. 293\u2013299. https:\/\/doi.org\/10.1124\/jpet.115.231456.","DOI":"10.1124\/jpet.115.231456"},{"key":"8120_CR110","doi-asserted-by":"publisher","unstructured":"Huete-Toral F, Crooke A, Mart\u00ednez-\u00c1guila A, J. Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells. J Pharmacol Exp Ther. 2015;352(1):p. 119\u2013128. https:\/\/doi.org\/10.1124\/jpet.114.218263.","DOI":"10.1124\/jpet.114.218263"},{"key":"8120_CR111","doi-asserted-by":"publisher","unstructured":"Andres-Guerrero V, Alarma-Estrany P, Molina-Mart\u00ednez IT, Peral A, Herrero-Vanrell R, Pintor J. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT. Exp Eye Res. Exp Eye Res. 2009;88(3):p.504\u2013511. https:\/\/doi.org\/10.1016\/j.exer.2008.11.004.","DOI":"10.1016\/j.exer.2008.11.004"},{"key":"8120_CR112","doi-asserted-by":"publisher","unstructured":"Serle JB, Wang R-F, Peterson WM, Plourde R, BR. Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes. J Glaucoma. 2004;13(5):p. 385\u2013388. https:\/\/doi.org\/10.1097\/01.ijg.0000133150.44686.0b.","DOI":"10.1097\/01.ijg.0000133150.44686.0b"},{"key":"8120_CR113","doi-asserted-by":"publisher","unstructured":"Reyes-Resina I, et al. Expression of Melatonin and dopamine D(3) receptor heteromers in Eye ciliary body epithelial cells and negative correlation with ocular hypertension. Cells. 2020;9(1). https:\/\/doi.org\/10.3390\/cells9010152.","DOI":"10.3390\/cells9010152"},{"key":"8120_CR114","doi-asserted-by":"publisher","unstructured":"Alkozi H, et al. Elevated intraocular pressure increases melatonin levels in the aqueous humour. Acta Ophthalmol. 2017;95(3):p. e185\u2013e189. https:\/\/doi.org\/10.1111\/aos.13253.","DOI":"10.1111\/aos.13253"},{"key":"8120_CR115","doi-asserted-by":"publisher","unstructured":"Alkozi HA, Pintor J. TRPV4 activation triggers the release of melatonin from human non-pigmented ciliary epithelial cells. Exp Eye Res. 2015;136:p. 34\u201337. https:\/\/doi.org\/10.1016\/j.exer.2015.04.019.","DOI":"10.1016\/j.exer.2015.04.019"},{"key":"8120_CR116","doi-asserted-by":"publisher","unstructured":"Khatib TZ, KR. Neuroprotection in glaucoma: towards clinical trials and precision medicine. Curr Eye Res. 2020;45(3):p. 327\u2013338. https:\/\/doi.org\/10.1080\/02713683.2019.1663385.","DOI":"10.1080\/02713683.2019.1663385"},{"key":"8120_CR117","doi-asserted-by":"publisher","unstructured":"Ebrahimi R, Farsi Y, Nejadghaderi SA. Fecal microbiota transplantation for glaucoma; a potential emerging treatment strategy. Curr Res Microb Sci. 2024. https:\/\/doi.org\/10.1016\/j.crmicr.2024.100314.","DOI":"10.1016\/j.crmicr.2024.100314"},{"issue":"20","key":"8120_CR118","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.3390\/foods11203302","volume":"11","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Xie Z, Wu D, Liu L, Shi Y, Li P, et al. The effect of indole-3-lactic acid from Lactiplantibacillus plantarum ZJ316 on human intestinal microbiota in vitro. Foods. 2022;11(20):3302. https:\/\/doi.org\/10.3390\/foods11203302.","journal-title":"Foods"},{"key":"8120_CR119","doi-asserted-by":"publisher","unstructured":"Wang Q, Liang J, Zou Q, Wang W, Yan G, Guo R, et al. Tryptophan metabolism-regulating Probiotics alleviate hyperuricemia by protecting the gut barrier integrity and enhancing colonic uric acid excretion. J. Agric. Food Chem. 2024;72(48):p. 26746\u201326761. https:\/\/doi.org\/10.1021\/acs.jafc.4c07716.","DOI":"10.1021\/acs.jafc.4c07716"},{"key":"8120_CR120","doi-asserted-by":"publisher","unstructured":"Rau S, et al. Prebiotics and Probiotics for gastrointestinal disorders. Nutrients. 2024;16(6). https:\/\/doi.org\/10.3390\/nu16060778.","DOI":"10.3390\/nu16060778"},{"key":"8120_CR121","doi-asserted-by":"publisher","unstructured":"Charbonneau MR, Isabella VM, Li N, Kurtz CB. Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nat Commun. 2020;11(1):p. 1738. https:\/\/doi.org\/10.1038\/s41467-020-15508-1.","DOI":"10.1038\/s41467-020-15508-1"},{"key":"8120_CR122","doi-asserted-by":"publisher","unstructured":"Vaaben TH, L\u00fctzh\u00f8ft DO, Koulouktsis A, Dawoodi IM, Stavnsbjerg C, Kvich L, et al. Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite. EMBO Rep. 2025;26(7):p. 1688\u20131708. https:\/\/doi.org\/10.1038\/s44319-025-00386-9.","DOI":"10.1038\/s44319-025-00386-9"},{"key":"8120_CR123","doi-asserted-by":"publisher","first-page":"142250","DOI":"10.1016\/j.ijbiomac.2025.142250","volume":"307","author":"X Gao","year":"2025","unstructured":"Gao X, Sun Y, Yang Y, Yang X, Liu Q, Guo X, et al. Directed evolution of hydroxylase XcP4H for enhanced 5-HTP production in engineered probiotics to treat depression. Int J Biol Macromolecules. 2025;307:142250. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142250.","journal-title":"Int J Biol Macromolecules"},{"key":"8120_CR124","doi-asserted-by":"publisher","first-page":"109690","DOI":"10.1016\/j.neuropharm.2023.109690","volume":"239","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Chen Y, He H, Peng M, Zeng M, Sun H. The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: a focus on human neurological and neuropsychiatric diseases. Neuropharmacology. 2023;239:109690. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109690.","journal-title":"Neuropharmacology"},{"key":"8120_CR125","doi-asserted-by":"publisher","unstructured":"Sinha AK, Laursen MF, Brinck JE, Rybtke ML, Hj\u00f8rne AP, Proch\u00e1zkov\u00e1 N, et al. Dietary fibre directs microbial tryptophan metabolism via metabolic interactions in the gut microbiota. Nat Microbiol. 2024;9(8):p. 1964\u20131978. https:\/\/doi.org\/10.1038\/s41564-024-01737-3.","DOI":"10.1038\/s41564-024-01737-3"},{"key":"8120_CR126","doi-asserted-by":"publisher","unstructured":"Wrzosek L, et al. Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury. Gut. 2021;70(7):p. 1299\u20131308. https:\/\/doi.org\/10.1136\/gutjnl-2020-321565.","DOI":"10.1136\/gutjnl-2020-321565"},{"key":"8120_CR127","doi-asserted-by":"publisher","unstructured":"Hofmeister M, Clement F, Patten S, Li J, Dowsett LE, Farkas B, et al. The effect of interventions targeting gut microbiota on depressive symptoms: a systematic review and meta-analysis. Cmajo. 2021;9(4):p. E1195\u2013E1204. https:\/\/doi.org\/10.9778\/cmajo.20200283.","DOI":"10.9778\/cmajo.20200283"},{"key":"8120_CR128","doi-asserted-by":"publisher","unstructured":"Mosa FES, Alqahtani MA, El-Ghiaty MA, Dyck JRB, Barakat K, El-Kadi AOS. Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugs. Drug Dev Res. 2024;85(5):p. e22232. https:\/\/doi.org\/10.1002\/ddr.22232.","DOI":"10.1002\/ddr.22232"},{"key":"8120_CR129","doi-asserted-by":"publisher","unstructured":"Xiao H, Mei N, Chi Q, Wang X. Comprehensive binding analysis of polybrominated diphenyl ethers and aryl hydrocarbon receptor via an integrated molecular modeling approach. Chemosphere. 2021;262:p. 128356. https:\/\/doi.org\/10.1016\/j.chemosphere.2020.128356.","DOI":"10.1016\/j.chemosphere.2020.128356"},{"key":"8120_CR130","doi-asserted-by":"publisher","unstructured":"Alluli A, Rijnbout St. James W, Eidelman DH, Baglole CJ. Dynamic relationship between the aryl hydrocarbon receptor and long noncoding RNA balances cellular and toxicological responses. Biochemical Pharmacol. 2023;216:p. 115745. https:\/\/doi.org\/10.1016\/j.bcp.2023.115745.","DOI":"10.1016\/j.bcp.2023.115745"},{"key":"8120_CR131","doi-asserted-by":"publisher","unstructured":"Nadeem U, Boachie-Mensah M, Zhang J, D. Gut microbiome and retinal diseases: an updated review. Curr Opin Ophthalmol. 2022;33(3):p. 195\u2013201. https:\/\/doi.org\/10.1097\/ICU.0000000000000836.","DOI":"10.1097\/ICU.0000000000000836"},{"key":"8120_CR132","doi-asserted-by":"publisher","unstructured":"Jiang Z-M, Zeng S-L, Huang T-Q, Lin Y, Wang F-F, Gao X-J, et al. Sinomenine ameliorates rheumatoid arthritis by modulating tryptophan metabolism and activating aryl hydrocarbon receptor via gut microbiota regulation. Sci Bull. 2023;68(14):p. 1540\u20131555. https:\/\/doi.org\/10.1016\/j.scib.2023.06.027.","DOI":"10.1016\/j.scib.2023.06.027"},{"key":"8120_CR133","doi-asserted-by":"publisher","unstructured":"Wang D, Wu J, Zhu P, Xie H, Lu L, Bai W, et al. Tryptophan-rich diet ameliorates chronic unpredictable mild stress induced depression- and anxiety-like behavior in mice: the potential involvement of gut-brain axis. Food Res Int. 2022;157:p. 111289. https:\/\/doi.org\/10.1016\/j.foodres.2022.111289.","DOI":"10.1016\/j.foodres.2022.111289"},{"key":"8120_CR134","doi-asserted-by":"publisher","unstructured":"Lu X, Qi C, Zheng J, Sun M, Jin L, Sun J. The antidepressant effect of deoiled sunflower seeds on chronic unpredictable mild stress in mice through regulation of microbiota\u2013gut\u2013brain axis. Front Nutr. 2022;9. https:\/\/doi.org\/10.3389\/fnut.2022.908297.","DOI":"10.3389\/fnut.2022.908297"},{"key":"8120_CR135","doi-asserted-by":"publisher","first-page":"134148","DOI":"10.1016\/j.foodchem.2022.134148","volume":"401","author":"S Qin","year":"2023","unstructured":"Qin S, Zhang K, Ding X, Bai S, Wang J, Tian G, et al. Microbiome-metabolomics analysis insight into the effects of dietary resistant starch on intestinal integrity. Food Chem: X. 2023;401:134148. https:\/\/doi.org\/10.1016\/j.foodchem.2022.134148.","journal-title":"Food Chem: X"},{"key":"8120_CR136","doi-asserted-by":"publisher","first-page":"112179","DOI":"10.1016\/j.foodres.2022.112179","volume":"163","author":"T Yan","year":"2023","unstructured":"Yan T, Shi L, Liu T, Zhang X, Yang M, Peng W, et al. Diet-rich in wheat bran modulates tryptophan metabolism and AhR\/IL-22 signalling mediated metabolic health and gut dysbacteriosis: a novel prebiotic-like activity of wheat bran. Food Res Int. 2023;163:112179. https:\/\/doi.org\/10.1016\/j.foodres.2022.112179.","journal-title":"Food Res Int"},{"key":"8120_CR137","doi-asserted-by":"publisher","unstructured":"Sun P, Wang M, Liu Y-X, Li L, Chai X, Zheng W, et al. High-fat diet-disturbed gut microbiota-colonocyte interactions contribute to dysregulating peripheral tryptophan-kynurenine metabolism. Microbiome. 2023;11(1). https:\/\/doi.org\/10.1186\/s40168-023-01606-x.","DOI":"10.1186\/s40168-023-01606-x"},{"key":"8120_CR138","doi-asserted-by":"publisher","unstructured":"Francis HM, Stevenson RJ, Tan LSY, Ehrenfeld L, Byeon S, Attuquayefio T, et al. Kynurenic acid as a biochemical factor underlying the association between Western-style diet and depression: a cross-sectional study. Front Nutr. 2022;9. https:\/\/doi.org\/10.3389\/fnut.2022.945538.","DOI":"10.3389\/fnut.2022.945538"},{"key":"8120_CR139","doi-asserted-by":"publisher","unstructured":"Udensi J, Loughman J, Loskutova E, Byrne HJ. Effects of supplementation of macular pigment carotenoids on ocular health: a Raman spectroscopic study of human blood serum of glaucoma patients. Analyst (Lond). 2025;150(4):p. 630\u2013641. https:\/\/doi.org\/10.1039\/d4an01337a.","DOI":"10.1039\/d4an01337a"},{"key":"8120_CR140","doi-asserted-by":"publisher","unstructured":"Rangel MVDS, Lopes KG, Qin X, Borges JP. Exercise-induced adaptations in the kynurenine pathway: implications for health and disease management. Front. Sports Act. Living. 2025;7. https:\/\/doi.org\/10.3389\/fspor.2025.1535152.","DOI":"10.3389\/fspor.2025.1535152"},{"issue":"3","key":"8120_CR141","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3390\/ijms24032863","volume":"24","author":"M Cantarini","year":"2023","unstructured":"Cantarini M, Rusciano D, Amato R, Canovai A, Cammalleri M, Monte MD, et al. Structural basis for agonistic activity and selectivity toward Melatonin receptors hMT1 and hMT2. IJMS. 2023;24(3):2863. https:\/\/doi.org\/10.3390\/ijms24032863.","journal-title":"IJMS"},{"key":"8120_CR142","doi-asserted-by":"publisher","first-page":"101556","DOI":"10.1016\/j.molmet.2022.101556","volume":"64","author":"P Petrus","year":"2022","unstructured":"Petrus P, Cervantes M, Samad M, Sato T, Chao A, Sato S, et al. Tryptophan metabolism is a physiological integrator regulating circadian rhythms. Mol Metab. 2022;64:101556. https:\/\/doi.org\/10.1016\/j.molmet.2022.101556.","journal-title":"Mol Metab"},{"key":"8120_CR143","doi-asserted-by":"publisher","unstructured":"He Z, Yang H, Mao Y. Time-restricted feeding changes as inspiration for drug design. CPD. 2023;29(8):p. 559\u2013561. https:\/\/doi.org\/10.2174\/1381612829666230307104103.","DOI":"10.2174\/1381612829666230307104103"},{"key":"8120_CR144","doi-asserted-by":"publisher","unstructured":"Xie J, Wu W-T, Chen J-J, Zhong Q, Wu D, Niu L, et al. Tryptophan metabolism as bridge between gut microbiota and brain in chronic social defeat stress-induced depression mice. Front Cell Infect Microbiol. 2023;13. https:\/\/doi.org\/10.3389\/fcimb.2023.1121445.","DOI":"10.3389\/fcimb.2023.1121445"},{"key":"8120_CR145","doi-asserted-by":"publisher","unstructured":"Contella L, et al. Impact of substance use disorder on tryptophan metabolism through the kynurenine pathway: a narrative review. Metabolites. 2024;14(11). https:\/\/doi.org\/10.3390\/metabo14110611.","DOI":"10.3390\/metabo14110611"},{"key":"8120_CR146","doi-asserted-by":"publisher","unstructured":"Xue C, et al. Tryptophan metabolism in health and disease. Cell Metab. 2023;35(8):p. 1304\u20131326. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.004.","DOI":"10.1016\/j.cmet.2023.06.004"},{"issue":"7","key":"8120_CR147","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/biom14070815","volume":"14","author":"S Hasterok","year":"2024","unstructured":"Hasterok S, Jankovskaja S, Miletic Dahlstr\u00f6m R, Prgomet Z, Ohlsson L, Bj\u00f6rklund S, et al. Exploring the surface: sampling of potential skin cancer biomarkers kynurenine and tryptophan, studied on 3D melanocyte and melanoma models. Biomolecules. 2024;14(7):815. https:\/\/doi.org\/10.3390\/biom14070815.","journal-title":"Biomolecules"},{"key":"8120_CR148","doi-asserted-by":"publisher","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 2012;13(7):465\u201377. https:\/\/doi.org\/10.1038\/nrn3257.","DOI":"10.1038\/nrn3257"},{"key":"8120_CR149","doi-asserted-by":"publisher","unstructured":"Connor TJ, Starr, O\u2019Sullivan JB, A, Starr N. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-\u03b3? Neurosci Lett. 2008;441(1):p. 29\u201334. https:\/\/doi.org\/10.1016\/j.neulet.2008.06.007.","DOI":"10.1016\/j.neulet.2008.06.007"},{"key":"8120_CR150","doi-asserted-by":"publisher","unstructured":"Chen B, Xie XK, Zhang J, Yang L, Zhou H, Zhang L, et al. Comprehensive analysis of mitochondrial dysfunction and necroptosis in intracranial aneurysms from the perspective of predictive, preventative, and personalized medicine. Apoptosis. 2023;28(9\u201310):p. 1452\u20131468. https:\/\/doi.org\/10.1007\/s10495-023-01865-x.","DOI":"10.1007\/s10495-023-01865-x"},{"key":"8120_CR151","doi-asserted-by":"publisher","unstructured":"Yu D, Yang TB, Du YY, Yang LS, He SS, Zhu XJ, et al. The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2015;43(1):p. 291\u2013302. https:\/\/doi.org\/10.3233\/JAD-140414.","DOI":"10.3233\/JAD-140414"},{"key":"8120_CR152","doi-asserted-by":"publisher","unstructured":"O\u2019Reilly K, O\u2019Farrell OFK, Midttun O, Rakovets Y, David -Bercholz J, A. Kynurenic acid protects against reactive glial-associated reductions in the complexity of primary cortical neurons. J Neuroimmune Pharmacol. 2021;16(3):p. 679\u2013692. https:\/\/doi.org\/10.1007\/s11481-020-09976-x.","DOI":"10.1007\/s11481-020-09976-x"},{"key":"8120_CR153","doi-asserted-by":"publisher","unstructured":"Breda C, Sathyasaikumar KV, Sograte Idrissi S, Notarangelo FM, Estranero JG, Moore GGL, et al. Tryptophan-2, 3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites. Proc Natl Acad Sci USA. 2016;113(19):p. 5435\u20135440. https:\/\/doi.org\/10.1073\/pnas.1604453113.","DOI":"10.1073\/pnas.1604453113"},{"key":"8120_CR154","doi-asserted-by":"publisher","unstructured":"Schwarcz R, TW. The kynurenine pathway and the brain: challenges, controversies and promises. Neuropharmacology. 2017;112(PtB):p. 237\u2013247. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.08.003.","DOI":"10.1016\/j.neuropharm.2016.08.003"},{"key":"8120_CR155","doi-asserted-by":"publisher","unstructured":"Amori L, Guidetti P, Pellicciari R, Kajii Y, Schwarcz R. On the relationship between the two branches of the kynurenine pathway in the rat brainin vivo. J Neurochem. 2009;109(2):p. 316\u2013325. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.05893.x.","DOI":"10.1111\/j.1471-4159.2009.05893.x"},{"key":"8120_CR156","doi-asserted-by":"publisher","unstructured":"Carpenedo R, Meli E, Peruginelli F, Pellegrini-Giampietro DE, Moroni F. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures. J Neurochem. 2002;82(6):p. 1465\u20131471. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.01090.x.","DOI":"10.1046\/j.1471-4159.2002.01090.x"},{"key":"8120_CR157","doi-asserted-by":"publisher","first-page":"109169","DOI":"10.1016\/j.neuropharm.2022.109169","volume":"215","author":"Y Bansal","year":"2022","unstructured":"Bansal Y, Singh R, Sodhi RK, Khare P, Dhingra R, Dhingra N, et al. Kynurenine monooxygenase inhibition and associated reduced quinolinic acid reverses depression-like behaviour by upregulating Nrf2\/ARE pathway in mouse model of depression: In-vivo and in-silico studies. Neuropharmacology. 2022;215:109169. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109169.","journal-title":"Neuropharmacology"},{"key":"8120_CR158","doi-asserted-by":"publisher","unstructured":"Dumont KD, Jannig PR, Porsmyr-Palmertz M, Ruas JL. Constitutive loss of kynurenine-3-monooxygenase changes circulating kynurenine metabolites without affecting systemic energy metabolism. Am J Physiol-Endoc M. 2025;328(2):p. E274\u2013E285. https:\/\/doi.org\/10.1152\/ajpendo.00386.2024.","DOI":"10.1152\/ajpendo.00386.2024"},{"key":"8120_CR159","doi-asserted-by":"publisher","unstructured":"Crozier-Reabe KR, Phillips RS, GR. Kynurenine 3-monooxygenase from Pseudomonas fluorescens: substrate-like inhibitors both stimulate flavin reduction and stabilize the Flavin\u2212Peroxo intermediate yet result in the production of hydrogen peroxide. Biochemistry. 2008;47(47):p. 12420\u201312433. https:\/\/doi.org\/10.1021\/bi8010434.","DOI":"10.1021\/bi8010434"},{"key":"8120_CR160","doi-asserted-by":"publisher","unstructured":"Jacobs KR, Castellano-Gonzalez G, Guillemin GJ, Lovejoy DB. Major developments in the design of inhibitors along the kynurenine pathway. CMC. 2017;24(23). https:\/\/doi.org\/10.2174\/0929867324666170502123114.","DOI":"10.2174\/0929867324666170502123114"},{"issue":"1","key":"8120_CR161","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/ph18010076","volume":"18","author":"R Rebai","year":"2025","unstructured":"Rebai R, Jasmin L, Boudah A. Identification of two flavonoids as New and safe inhibitors of kynurenine aminotransferase II via computational and in vitro study. Pharmaceuticals. 2025;18(1):76. https:\/\/doi.org\/10.3390\/ph18010076.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"8120_CR162","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/antiox11020315","volume":"11","author":"KV Sathyasaikumar","year":"2022","unstructured":"Sathyasaikumar KV, P\u00e9rez de la Cruz V, Pineda B, V\u00e1zquez Cervantes GI, Ram\u00edrez Ortega D, Donley DW, et al. Cellular localization of kynurenine 3-monooxygenase in the brain: challenging the dogma. Antioxid (Basel). 2022;11(2):315. https:\/\/doi.org\/10.3390\/antiox11020315.","journal-title":"Antioxid (Basel)"},{"key":"8120_CR163","doi-asserted-by":"publisher","unstructured":"Song C, Clark SM, Vaughn CN, Nicholson JD, Murphy KJ, Mou T-CM, et al. Quantitative analysis of kynurenine aminotransferase II in the adult rat brain Reveals high expression in proliferative zones and corpus callosum. Neuroscience. 2018;369:p. 1\u201314. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.11.001.","DOI":"10.1016\/j.neuroscience.2017.11.001"},{"key":"8120_CR164","doi-asserted-by":"publisher","unstructured":"Cao Y, Popp O, Milani N, Qadri F, K\u00fchn R, Mertins P, et al. Hyperphenylalaninemia and serotonin deficiency in Dnajc12-deficient mice. Commun Biol. 2024;7(1). https:\/\/doi.org\/10.1038\/s42003-024-07360-6.","DOI":"10.1038\/s42003-024-07360-6"},{"issue":"10","key":"8120_CR165","doi-asserted-by":"publisher","first-page":"102429","DOI":"10.1016\/j.jbc.2022.102429","volume":"298","author":"S Yin","year":"2022","unstructured":"Yin S, Pang A, Liu C, Li Y, Liu N, Li S, et al. Peptide OM-LV20 protects astrocytes against oxidative stress via the \u2018PAC1R\/JNK\/TPH1\u2019 axis. J Biol Chem. 2022;298(10):102429. https:\/\/doi.org\/10.1016\/j.jbc.2022.102429.","journal-title":"J Biol Chem"},{"key":"8120_CR166","doi-asserted-by":"publisher","first-page":"105831","DOI":"10.1016\/j.neuint.2024.105831","volume":"179","author":"C Banerjee","year":"2024","unstructured":"Banerjee C, Tripathy D, Kumar D, Chakraborty J. Monoamine oxidase and neurodegeneration: mechanisms, inhibitors and natural compounds for therapeutic intervention. Neurochemistry Int. 2024;179:105831. https:\/\/doi.org\/10.1016\/j.neuint.2024.105831.","journal-title":"Neurochemistry Int"},{"key":"8120_CR167","doi-asserted-by":"crossref","unstructured":"Szil\u00e1gyi A, Tak\u00e1cs B, Szekeres R, Tarj\u00e1nyi V, Bombicz M, Priksz D, et al. Therapeutic properties of ayahuasca components in Ischemia\/Reperfusion injury of the Eye. Biomedicines. 2022;10(5): 10.3390\/biomedicines10050997.","DOI":"10.3390\/biomedicines10050997"},{"key":"8120_CR168","doi-asserted-by":"publisher","unstructured":"Dhangar MS, et al. Optimizing Linezolid: transforming it into a selective MAO-B inhibitor via a toxicity-to-activity optimization approach. ACS Med Chem Lett. 2024;16(1):p. 40\u201350. https:\/\/doi.org\/10.1021\/acsmedchemlett.4c00354.","DOI":"10.1021\/acsmedchemlett.4c00354"},{"key":"8120_CR169","doi-asserted-by":"publisher","first-page":"105599","DOI":"10.1016\/j.yhbeh.2024.105599","volume":"164","author":"T Ghorbandaiepour","year":"2024","unstructured":"Ghorbandaiepour T, Sadroddiny E, Zahmatkesh M, Hassanzadeh G. Inhibition of hippocampal melatonin synthesis by siRNA induced learning and memory deficits in male rats. Horm Behav. 2024;164:105599. https:\/\/doi.org\/10.1016\/j.yhbeh.2024.105599.","journal-title":"Horm Behav"},{"key":"8120_CR170","doi-asserted-by":"publisher","unstructured":"Yang H, et al. RP58 knockdown contributes to hypoxia-ischemia-induced pineal dysfunction and circadian rhythm disruption in neonatal rats. J Pineal Res. 2023;75(1). https:\/\/doi.org\/10.1111\/jpi.12885.","DOI":"10.1111\/jpi.12885"},{"key":"8120_CR171","doi-asserted-by":"publisher","unstructured":"Akada M, Nakanishi Y, Ideyama M, Mori Y, Morino K, Nakano E, et al. Sleep disturbance as a risk factor for retinal neurodegeneration and subsequent glaucoma. Am J Ophthalmol. 2025;280:p. 193\u2013202. https:\/\/doi.org\/10.1016\/j.ajo.2025.08.019.","DOI":"10.1016\/j.ajo.2025.08.019"},{"issue":"5","key":"8120_CR172","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3390\/microorganisms11051355","volume":"11","author":"EAC Hababag","year":"2023","unstructured":"Hababag EAC, Cauilan A, Quintero D, Bermudes D. Tryptophanase expressed by salmonella halts breast cancer Cell growth in vitro and inhibits production of immunosuppressive Kynurenine. Microorganisms. 2023;11(5):1355. https:\/\/doi.org\/10.3390\/microorganisms11051355.","journal-title":"Microorganisms"},{"key":"8120_CR173","doi-asserted-by":"publisher","unstructured":"Kongjaroon S, Lawan N, Trisrivirat D, Chaiyen P. Enhancement of tryptophan 2-monooxygenase thermostability by semi-rational enzyme engineering: a strategic design to minimize experimental investigation. RSC Chem. Biol. 2024;5(10):p. 989\u20131001. https:\/\/doi.org\/10.1039\/d4cb00102h.","DOI":"10.1039\/d4cb00102h"},{"key":"8120_CR174","doi-asserted-by":"publisher","unstructured":"Wang G, Fan Y, Zhang G, Cai S, Ma Y, Yang L, et al. Microbiota-derived indoles alleviate intestinal inflammation and modulate microbiome by microbial cross-feeding. Microbiome. 2024;12(1). https:\/\/doi.org\/10.1186\/s40168-024-01750-y.","DOI":"10.1186\/s40168-024-01750-y"},{"key":"8120_CR175","doi-asserted-by":"publisher","first-page":"107331","DOI":"10.1016\/j.micpath.2025.107331","volume":"200","author":"J Che","year":"2025","unstructured":"Che J, Liu B, Fang Q, Nissa MU, Luo T, Wang L, et al. Biological studies reveal the role of trpA gene in biofilm formation, motility, hemolysis and virulence in Vibrio anguillarum. Microb Pathog. 2025;200:107331. https:\/\/doi.org\/10.1016\/j.micpath.2025.107331.","journal-title":"Microb Pathog"},{"key":"8120_CR176","doi-asserted-by":"publisher","unstructured":"Yuasa HJ. Metazoan tryptophan indole-lyase: are they still active? comparative Biochemistry and physiology part B. Comp Biochem Physiol B Biochem Mol Biol. 2023;263:110801. https:\/\/doi.org\/10.1016\/j.cbpb.2022.110801.","DOI":"10.1016\/j.cbpb.2022.110801"},{"key":"8120_CR177","doi-asserted-by":"publisher","unstructured":"Hammond CL, Roztocil E, Gupta V, Feldon SE, Woeller CF. More than meets the Eye: the aryl hydrocarbon receptor is an environmental sensor, physiological regulator and a therapeutic target in ocular disease. Front Toxicol. 2022;4:p. 791082. https:\/\/doi.org\/10.3389\/ftox.2022.791082.","DOI":"10.3389\/ftox.2022.791082"},{"key":"8120_CR178","doi-asserted-by":"publisher","unstructured":"Mosa FES, Alqahtani MA, El-Ghiaty MA, Barakat K, El-Kadi AOS. Identifying novel aryl hydrocarbon receptor (AhR) modulators from clinically approved drugs: in silico screening and in vitro validation. Archives Biochem Biophys. 2024;754: https:\/\/doi.org\/10.1016\/j.abb.2024.109958.","DOI":"10.1016\/j.abb.2024.109958"},{"key":"8120_CR179","doi-asserted-by":"publisher","unstructured":"Lee S-M, et al. Aryl hydrocarbon receptor-targeted therapy for CD4+ T cell-mediated idiopathic pneumonia syndrome in mice. Vol. 139 (22). Blood; 2022. p. p. 3325\u20133339. https:\/\/doi.org\/10.1182\/blood.2021013849.","DOI":"10.1182\/blood.2021013849"},{"key":"8120_CR180","doi-asserted-by":"publisher","first-page":"116769","DOI":"10.1016\/j.taap.2023.116769","volume":"482","author":"Z Kou","year":"2024","unstructured":"Kou Z, Tran F, Dai W. Heavy metals, oxidative stress, and the role of AhR signaling. Toxicol Appl Pharm. 2024;482:116769. https:\/\/doi.org\/10.1016\/j.taap.2023.116769.","journal-title":"Toxicol Appl Pharm"},{"key":"8120_CR181","doi-asserted-by":"publisher","unstructured":"Liu S. AHR regulates liver enlargement and regeneration through the YAP signaling pathway. Heliyon. 2024;10(17). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37265.","DOI":"10.1016\/j.heliyon.2024.e37265"},{"key":"8120_CR182","doi-asserted-by":"publisher","unstructured":"Vijay A, Boyle NR, Kumar SM, Perdew GH, Srinivasan S, Patterson AD. Aryl hydrocarbon receptor activation affects nitrergic neuronal survival and delays intestinal motility in mice. Toxicological Sci. 2023;192(1):p. 117\u2013128. https:\/\/doi.org\/10.1093\/toxsci\/kfad014.","DOI":"10.1093\/toxsci\/kfad014"},{"key":"8120_CR183","doi-asserted-by":"publisher","unstructured":"Houser CL, Lawrence BP. The aryl hydrocarbon receptor modulates T follicular Helper Cell responses to influenza virus infection in mice. J Immunol. 2022;208(10):p. 2319\u20132330. https:\/\/doi.org\/10.4049\/jimmunol.2100936.","DOI":"10.4049\/jimmunol.2100936"},{"issue":"5","key":"8120_CR184","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/pharmaceutics15051370","volume":"15","author":"GL Romano","year":"2023","unstructured":"Romano GL, Gozzo L, Maurel OM, Di Martino S, Riolo V, Micale V, et al. Fluoxetine protects retinal ischemic damage in mice. Pharmaceutics. 2023;15(5):1370. https:\/\/doi.org\/10.3390\/pharmaceutics15051370.","journal-title":"Pharmaceutics"},{"issue":"8","key":"8120_CR185","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s11064-024-04159-z","volume":"49","author":"K Jakubowska","year":"2024","unstructured":"Jakubowska K, Hogendorf AS, Go\u0142da S, Jantas D. Neuroprotective and neurite outgrowth stimulating effects of New low-basicity 5-HT7 receptor agonists: In Vitro study in human neuroblastoma SH-SY5Y cells. Neurochem Res. 2024;49(8):2179\u201396. https:\/\/doi.org\/10.1007\/s11064-024-04159-z.","journal-title":"Neurochem Res"},{"key":"8120_CR186","doi-asserted-by":"publisher","unstructured":"Gonzalez P, et al. The 5HT1a receptor agonist 8-oh DPAT induces protection from lipofuscin accumulation and oxidative stress in the retinal pigment epithelium. PLoS One. 2012;7(4). https:\/\/doi.org\/10.1371\/journal.pone.0034468.","DOI":"10.1371\/journal.pone.0034468"},{"key":"8120_CR187","doi-asserted-by":"publisher","unstructured":"Barbosa-M\u00e9ndez S, Perez-S\u00e1nchez G, A. Agomelatine decreases cocaine-induced locomotor sensitisation and dopamine release in rats. World J Biol Psychiatry. 2023;24(5):p. 400\u2013413. https:\/\/doi.org\/10.1080\/15622975.2022.2123954.","DOI":"10.1080\/15622975.2022.2123954"},{"issue":"20","key":"8120_CR188","doi-asserted-by":"publisher","first-page":"11243","DOI":"10.3390\/ijms252011243","volume":"25","author":"H-J Yoon","year":"2024","unstructured":"Yoon H-J, Jiang E, Liu J, Jin H, Yoon HS, Choi JS, et al. A selective Melatonin 2 receptor agonist, IIK7, relieves blue light-induced corneal damage by modulating the process of autophagy and Apoptosis. IJMS. 2024;25(20):11243. https:\/\/doi.org\/10.3390\/ijms252011243.","journal-title":"IJMS"},{"key":"8120_CR189","doi-asserted-by":"publisher","unstructured":"Liu M, Li H, Yang R, Ji D, Xia X. GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1\/RIP3\/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma. J Neuroinflammation. 2022;19(1). https:\/\/doi.org\/10.1186\/s12974-022-02626-4.","DOI":"10.1186\/s12974-022-02626-4"},{"key":"8120_CR190","doi-asserted-by":"publisher","first-page":"p. 1173","DOI":"10.12659\/msm.899699","volume-title":"Glioprotection of retinal astrocytes after Intravitreal administration of Memantine in the mouse optic nerve crush model","author":"R Maciulaitiene","year":"2017","unstructured":"Maciulaitiene R, et al. Glioprotection of retinal astrocytes after Intravitreal administration of Memantine in the mouse optic nerve crush model. Vol. 23. Medical Science Monitor; 2017. p. p. 1173\u20131179. https:\/\/doi.org\/10.12659\/msm.899699."},{"key":"8120_CR191","doi-asserted-by":"publisher","unstructured":"Mohamad MHN, Abu IF, Fazel MF, Agarwal R, Iezhitsa I, Juliana N, et al. Neuroprotection against NMDA-Induced retinal damage by philanthotoxin-343 involves reduced nitrosative stress. Front Pharmacol. 2021;12. https:\/\/doi.org\/10.3389\/fphar.2021.798794.","DOI":"10.3389\/fphar.2021.798794"},{"key":"8120_CR192","doi-asserted-by":"publisher","first-page":"107892","DOI":"10.1016\/j.exer.2019.107892","volume":"190","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang R, Chen J, Wu J. Neuroprotective effects of DAAO are mediated via the ERK1\/2 signaling pathway in a glaucomatous animal model. Exp Eye Res. 2020;190:107892. https:\/\/doi.org\/10.1016\/j.exer.2019.107892.","journal-title":"Exp Eye Res"},{"key":"8120_CR193","doi-asserted-by":"publisher","unstructured":"Ilochonwu BC, Urtti A, Hennink WE, Vermonden T. Intravitreal hydrogels for sustained release of therapeutic proteins. J Control Release. 2020;326:p. 419\u2013441. https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.031.","DOI":"10.1016\/j.jconrel.2020.07.031"},{"key":"8120_CR194","doi-asserted-by":"publisher","unstructured":"Nagy K, Plang\u00e1r I, Tuka B, Gell\u00e9rt L, Varga D, Demeter I, et al. Synthesis and biological effects of some kynurenic acid analogs. Bioorg Med Chem. 2011;19(24):p. 7590\u20137596. https:\/\/doi.org\/10.1016\/j.bmc.2011.10.029.","DOI":"10.1016\/j.bmc.2011.10.029"},{"issue":"6","key":"8120_CR195","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.3390\/ijms25063394","volume":"25","author":"D Martos","year":"2024","unstructured":"Martos D, L\u0151rinczi B, Szatm\u00e1ri I, V\u00e9csei L, Tanaka M. The Impact of C-3 side chain modifications on Kynurenic acid: a behavioral analysis of its analogs in the motor domain. IJMS. 2024;25(6):3394. https:\/\/doi.org\/10.3390\/ijms25063394.","journal-title":"IJMS"},{"key":"8120_CR196","doi-asserted-by":"publisher","unstructured":"Anastassova N, et al. New indole-3-propionic acid and 5-methoxy-indole carboxylic acid derived hydrazone hybrids as Multifunctional neuroprotectors. Antioxidants. 2023;12(4). https:\/\/doi.org\/10.3390\/antiox12040977.","DOI":"10.3390\/antiox12040977"},{"issue":"18","key":"8120_CR197","doi-asserted-by":"publisher","first-page":"14251","DOI":"10.3390\/ijms241814251","volume":"24","author":"\u00c1 Juh\u00e1sz","year":"2023","unstructured":"Juh\u00e1sz \u00c1, Ungor D, Varga N, Katona G, Balogh GT, Csap\u00f3 E. Lipid-based nanocarriers for delivery of neuroprotective Kynurenic acid: preparation, characterization, and BBB transport. IJMS. 2023;24(18):14251. https:\/\/doi.org\/10.3390\/ijms241814251.","journal-title":"IJMS"},{"key":"8120_CR198","doi-asserted-by":"publisher","first-page":"112935","DOI":"10.1016\/j.colsurfb.2022.112935","volume":"220","author":"V Hornok","year":"2022","unstructured":"Hornok V, Amin KWK, Kov\u00e1cs AN, Juh\u00e1sz \u00c1, Katona G, Balogh GT, et al. Increased blood-brain barrier permeability of neuroprotective drug by colloidal serum albumin carriers. Colloids Surf B Biointerfaces. 2022;220:112935. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112935.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"4","key":"8120_CR199","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/pharmaceutics15041096","volume":"15","author":"P Colucci","year":"2023","unstructured":"Colucci P, Giannaccini M, Baggiani M, Kennedy BN, Dente L, Raffa V, et al. Neuroprotective nanoparticles targeting the retina: a polymeric platform for ocular drug delivery applications. Pharmaceutics. 2023;15(4):1096. https:\/\/doi.org\/10.3390\/pharmaceutics15041096.","journal-title":"Pharmaceutics"},{"key":"8120_CR200","doi-asserted-by":"publisher","unstructured":"Fang X, Wu Y, Dai Y, Xiao H, Li S, Chen X, et al. In situ recovery of serotonin synthesis by a tryptophan hydroxylase-like Nanozyme for the treatment of depression. J. Am. Chem. Soc. 2025;147(11):p. 9111\u20139121. https:\/\/doi.org\/10.1021\/jacs.4c10733.","DOI":"10.1021\/jacs.4c10733"},{"issue":"5","key":"8120_CR201","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3390\/pharmaceutics15051484","volume":"15","author":"D Rafael","year":"2023","unstructured":"Rafael D, Guerrero M, Marican A, Arango D, Sarmento B, Ferrer R, et al. Delivery systems in ocular retinopathies: the promising future of intravitreal hydrogels as sustained-release scaffolds. Pharmaceutics. 2023;15(5):1484. https:\/\/doi.org\/10.3390\/pharmaceutics15051484.","journal-title":"Pharmaceutics"},{"key":"8120_CR202","doi-asserted-by":"publisher","unstructured":"Chen J, Cui L, Lu S, Xu S. Amino acid metabolism in tumor biology and therapy. Cell Death Dis. 2024;15(1):p. 42. https:\/\/doi.org\/10.1038\/s41419-024-06435-w.","DOI":"10.1038\/s41419-024-06435-w"},{"key":"8120_CR203","doi-asserted-by":"publisher","unstructured":"Lieben CK, et al. Intake of tryptophan-enriched whey protein acutely enhances recall of positive loaded words in patients with multiple sclerosis. Clin Nutr. 2018;37(1):p. 321\u2013328. https:\/\/doi.org\/10.1016\/j.clnu.2016.12.029.","DOI":"10.1016\/j.clnu.2016.12.029"},{"key":"8120_CR204","doi-asserted-by":"publisher","unstructured":"Mace JL, Porter RJ, Dalrymple-Alford JC, Collins C, Anderson TJ. Acute tryptophan depletion and Lewy body dementias. Int Psychogeriatrics. 2016;28(9):p. 1487\u20131491. https:\/\/doi.org\/10.1017\/s1041610216000284.","DOI":"10.1017\/s1041610216000284"},{"key":"8120_CR205","doi-asserted-by":"publisher","unstructured":"Porter RJ, Lunn BS, Walker LLM, Gray JM, Ballard, JT, et al. Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimer\u2019s disease. AJP. 2000;157(4):p. 638\u2013640. https:\/\/doi.org\/10.1176\/appi.ajp.157.4.638.","DOI":"10.1176\/appi.ajp.157.4.638"},{"key":"8120_CR206","doi-asserted-by":"publisher","unstructured":"Scholtissen B, Verhey FRJ, Adam JJ, Prickaerts J, Leentjens AFG. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson\u2019s disease. J Neurological Sci. 2006;248(1\u20132):p. 259\u2013265. https:\/\/doi.org\/10.1016\/j.jns.2006.05.029.","DOI":"10.1016\/j.jns.2006.05.029"},{"key":"8120_CR207","doi-asserted-by":"publisher","unstructured":"Bansi J, Koliamitra C, Bloch W, Joisten N, Schenk A, Watson M, et al. Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training. J Neuroimmunol. 2018;314:p. 101\u2013105. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.12.001.","DOI":"10.1016\/j.jneuroim.2017.12.001"},{"key":"8120_CR208","doi-asserted-by":"publisher","unstructured":"Joisten N, Rademacher A, Warnke C, Proschinger S, Schenk A, Walzik D, et al. Exercise diminishes plasma Neurofilament light chain and reroutes the kynurenine pathway in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021;8(3). https:\/\/doi.org\/10.1212\/nxi.0000000000000982.","DOI":"10.1212\/nxi.0000000000000982"},{"key":"8120_CR209","unstructured":"Miller EM, HA. L-tryptophan in the treatment of levodopa induced psychiatric disorders. Dis Nerv Syst. 1974;35(1):20\u201323."},{"key":"8120_CR210","doi-asserted-by":"publisher","unstructured":"Hyypp? MT, Jolma JT, Riekkinen P, UK. Effects of L-tryptophan treatment on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. J. Neural Transm. 1975;37(4):p. 297\u2013304. https:\/\/doi.org\/10.1007\/BF01258656.","DOI":"10.1007\/BF01258656"},{"key":"8120_CR211","doi-asserted-by":"publisher","unstructured":"Coppen A, Carroll MM, Morris JD, JG. Levodopa and L-tryptophan therapy in parkinsonism. Vol. 1 (7752). Lancet; 1972. p. p. 654\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(72)90461-8.","DOI":"10.1016\/s0140-6736(72)90461-8"},{"key":"8120_CR212","doi-asserted-by":"publisher","unstructured":"Yi C, Pan X, Yan H, Guo M, Pierpaoli W. Effects of Melatonin in Age-related macular degeneration. Ann New Y Acad Sci. 2005;1057(1):p. 384\u2013392. https:\/\/doi.org\/10.1196\/annals.1356.029.","DOI":"10.1196\/annals.1356.029"},{"issue":"3","key":"8120_CR213","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mds.870030308","volume":"3","author":"R Mayeux","year":"1988","unstructured":"Mayeux R, Stern Y, Sano M, Williams JBW, Cote LJ. The relationship of serotonin to depression in Parkinson\u2019s disease. Mov Disord. 1988;3(3):237\u201344. https:\/\/doi.org\/10.1002\/mds.870030308.","journal-title":"Mov Disord"},{"key":"8120_CR214","doi-asserted-by":"publisher","unstructured":"Jaffe GJ, Schmitz-Valckenberg S, Boyer D, Heier J, Wolf-Schnurrbusch U, Staurenghi G, et al. Randomized trial to evaluate tandospirone in geographic atrophy secondary to Age-related macular degeneration: the GATE study. Am J Ophthalmol. 2015;160(6):p. 1226\u20131234. https:\/\/doi.org\/10.1016\/j.ajo.2015.08.024.","DOI":"10.1016\/j.ajo.2015.08.024"},{"key":"8120_CR215","doi-asserted-by":"publisher","unstructured":"Tohgi H, Abe AT, Takahashi S, Saheki M, M. Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor. J Neural Transm Gen Sect. 1995;9(2\u20133):p. 121\u2013131. https:\/\/doi.org\/10.1007\/BF02259654.","DOI":"10.1007\/BF02259654"},{"key":"8120_CR216","doi-asserted-by":"publisher","unstructured":"Tian P, Chen Y, Zhu H, Wang L, Qian X, Zou R, et al. Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: a randomized clinical trial. Brain Behav Immun. 2022;100:p. 233\u2013241. https:\/\/doi.org\/10.1016\/j.bbi.2021.11.023.","DOI":"10.1016\/j.bbi.2021.11.023"},{"key":"8120_CR217","doi-asserted-by":"publisher","unstructured":"Rudzki L, Ostrowska L, Pawlak D, Ma\u0142us A, Pawlak K, Waszkiewicz N, et al. Probiotic Lactobacillus plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: a double-blind, randomized, placebo controlled study. Psychoneuroendocrinology. 2019;100:p. 213\u2013222. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.10.010.","DOI":"10.1016\/j.psyneuen.2018.10.010"},{"key":"8120_CR218","doi-asserted-by":"publisher","unstructured":"Kim C-S, Jung S, Hwang G-S, Shin D-M. Gut microbiota indole-3-propionic acid mediates neuroprotective effect of probiotic consumption in healthy elderly: a randomized, double-blind, placebo-controlled, multicenter trial and in vitro study. Clin Nutr. 2023;42(6):p. 1025\u20131033. https:\/\/doi.org\/10.1016\/j.clnu.2023.04.001.","DOI":"10.1016\/j.clnu.2023.04.001"},{"key":"8120_CR219","doi-asserted-by":"publisher","unstructured":"Klinkenberg S, van den Borne CJH, Aalbers MW, Verschuure P, Kessels AG, Leenen L, et al. The effects of vagus nerve stimulation on tryptophan metabolites in children with intractable epilepsy. Epilepsy Behav. 2014;37:p. 133\u2013138. https:\/\/doi.org\/10.1016\/j.yebeh.2014.06.001.","DOI":"10.1016\/j.yebeh.2014.06.001"},{"key":"8120_CR220","doi-asserted-by":"publisher","unstructured":"Amirkhani A, Rajda C, Arvidsson B, Bencsik K, Boda K, Seres E, et al. Interferon-\u03b2 affects the tryptophan metabolism in multiple sclerosis patients. Euro J Neurol. 2005;12(8):p. 625\u2013631. https:\/\/doi.org\/10.1111\/j.1468-1331.2005.01041.x.","DOI":"10.1111\/j.1468-1331.2005.01041.x"},{"key":"8120_CR221","doi-asserted-by":"publisher","unstructured":"Pukaluk A, Sommer G, Holzapfel GA. Multimodal experimental studies of the passive Mechanical behavior of human aortas: current approaches and future directions. Acta Biomater. 2024;178:p. 1\u201312. https:\/\/doi.org\/10.1016\/j.actbio.2024.02.026.","DOI":"10.1016\/j.actbio.2024.02.026"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08120-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08120-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08120-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:31:31Z","timestamp":1780623091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08120-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":221,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8120"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08120-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"741"}}